Cargando…
Translational Issues with the Development of Cognition Enhancing Drugs
Autores principales: | Blokland, Arjan, van Goethem, Nick, Heckman, Pim, Schreiber, Rudy, Prickaerts, Jos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4174861/ https://www.ncbi.nlm.nih.gov/pubmed/25309509 http://dx.doi.org/10.3389/fneur.2014.00190 |
Ejemplares similares
-
Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial
por: Heckman, Pim R. A., et al.
Publicado: (2017) -
Why an M1 Antagonist Could Be a More Selective Model for Memory Impairment than Scopolamine
por: Blokland, Arjan, et al.
Publicado: (2016) -
Pro-cognitive effect of upregulating cyclic guanosine monophosphate signalling during memory acquisition or early consolidation is mediated by increased AMPA receptor trafficking
por: Argyrousi, Elentina K, et al.
Publicado: (2019) -
Targeting cyclic nucleotides in CNS drug discovery: a translational approach into cognition enhancement
por: Prickaerts, Jos
Publicado: (2015) -
Selective phosphodiesterase inhibitors: a promising target for cognition enhancement
por: Reneerkens, Olga A. H., et al.
Publicado: (2008)